Videos / Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Hayley Ryan
Management of Skin Tear in General Practice
Clinical Prof Sheryl Van Nunen OAM
Mammalian Meat Allergy & Tick Bites Explainer
Prof Sebastian King
Paediatric Bowel Dysfunction
Dr Katherine Spira
Migraine
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
